查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595564

早洩治疗市场：按药物类型、剂型、分销管道划分 - 全球预测 2025-2030

Premature Ejaculation Treatment Market by Drug Type (Dapoxetine, Phosphodiesterase Type 5 Inhibitors, Selective Serotonin Reuptake Inhibitors), Type, Dosage Form, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年早洩治疗市场规模为35.2亿美元，预计2024年将达38.6亿美元，复合年增长率为9.80%，2030年将达67.7亿美元。

早洩 (PE) 治疗市场包括多种旨在管理或解决这种常见男性性功能障碍的产品和治疗方法。 PE 的定义是射精发生得比预期早，可能会导致痛苦和人际关係问题，凸显了有效介入的必要性。治疗方法包括从口服药物解决方案（如 SSRIs）到行为疗法和局部麻醉剂，以解决身体和心理的方面。主要最终用户包括医疗保健提供者以及寻求临床建议和非处方药的不同年龄层的男性。该市场的主要成长动力包括健康意识的提高、药品的进步以及社会的转变以更公开地讨论男性性健康。技术进步和研发措施为开发创新治疗方法和个人化医疗保健解决方案提供了肥沃的土壤。特别是，远端医疗和电子商务平台的出现正在扩大治疗范围，并为市场参与者创造新的机会。然而，耻辱感、欠发达地区消费者缺乏意识以及治疗潜在副作用等限制因素继续挑战着成长。监管障碍和大规模临床试验的需要也减缓了新药的推出。在创新方面，个人化医疗和人工智慧的整合以实现更好的诊断和治疗客製化是有前途的。对非侵入性治疗和自然疗法的探索提供了潜在的创新途径。竞争格局充满活力，既有成熟的製药巨头，也有灵活的新兴企业，反映了强劲但复杂的市场特征。寻求扩张的公司应利用数位平台扩大对消费者的影响力，并参与研发合作以维持长期成长。透过提高认识宣传活动解决教育障碍并消除疾病污染可以进一步提高市场渗透率和消费者参与。

主要市场统计
基准年[2023] 35.2亿美元
预测年份 [2024] 38.6亿美元
预测年份 [2030] 67.7亿美元
复合年增长率（%） 9.80%

市场动态：揭示快速发展的早洩治疗市场的关键市场洞察

供需的动态交互作用正在改变早洩治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 提高政府对早洩的认识
    • 早洩盛行率增加
    • 透过远端医疗进行治疗的可能性
  • 市场限制因素
    • 与早洩治疗相关的副作用
  • 市场机会
    • 增加治疗药物的研发
    • 增加策略联盟以开发新的诊断工具
  • 市场挑战
    • 医护人员短缺

波特的五力策略工具驾驭早洩治疗市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解早洩治疗市场的外在影响

外在宏观环境因素对早洩治疗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解早洩治疗市场的竞争状况

对早洩治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵早洩治疗市场供应商的绩效评估

FPNV定位矩阵是评估早洩治疗市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划早洩治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对早洩治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 意识提升
      • 早洩增加
      • 透过远端医疗进行治疗的可用性
    • 抑制因素
      • 与早洩治疗相关的副作用
    • 机会
      • 增加治疗药物的研发
      • 加强策略合作开发新诊断工具
    • 任务
      • 医护人员短缺
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 早洩治疗市场药物按类型

  • 达泊西汀
  • 5 型磷酸二酯酶 (PDE5) 抑制剂
  • 选择性血清素再回收抑制剂
  • 局部麻醉剂
  • 泽尔坦

第七章早洩治疗市场：依类型

  • 口腔治疗
    • 非选择性血清素再回收抑制剂
    • 选择性血清素再回收抑制剂
  • 局部治疗

第八章早洩治疗市场（以剂型）

  • 锭剂
  • 喷

第九章早洩治疗市场：依通路分类

  • 医院
  • 网路药房
  • 零售药房

第十章北美及南美早洩治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区早洩治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的早洩治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Ampio Pharmaceuticals, Inc.
  • Aytu BioPharma, Inc.
  • Bayer AG
  • Donga Pharmaceutical Co.,Ltd.
  • Eli Lilly and Company
  • Emcure Pharmaceuticals
  • Futura Medical PLC
  • GlaxoSmithKline PLC
  • Hetero Healthcare Limited
  • Menarini Group
  • NeuroHealing Pharmaceuticals Inc.
  • Pfizer Inc.
  • Veru Inc.
  • Wholesome Medtech Private Limited
  • zr pharma& GmbH
Product Code: MRR-030EE48515EB

The Premature Ejaculation Treatment Market was valued at USD 3.52 billion in 2023, expected to reach USD 3.86 billion in 2024, and is projected to grow at a CAGR of 9.80%, to USD 6.77 billion by 2030.

The treatment market for premature ejaculation (PE) encompasses a wide array of products and therapies aimed at managing or resolving this common male sexual dysfunction. Defined as ejaculation that occurs sooner than desired, PE can lead to distress and interpersonal issues, underlining the necessity for effective interventions. Treatments range from oral pharmacological solutions like SSRIs to behavioral therapies and topical anesthetics, catering to both physical and psychological facets. The primary end-users include men across various age groups seeking clinical advice or over-the-counter options, alongside healthcare providers. Key growth drivers in this market involve increasing health awareness, advancements in pharmaceuticals, and the societal shift towards more open discussions on male sexual health. Technological advancements and R&D initiatives provide fertile ground for developing innovative treatment modalities and personalized healthcare solutions. In particular, the advent of telemedicine and e-commerce platforms has expanded access to treatments, creating new opportunities for market players. However, limitations such as stigma, lack of consumer awareness in less developed regions, and potential side effects of treatments continue to challenge growth. Regulatory hurdles and the need for extensive clinical trials can also delay the introduction of new drugs. In terms of innovation, personalized medicine and integrating artificial intelligence for better diagnosis and therapy customization hold promise. Exploration in non-invasive treatments and natural therapies offers potential innovation routes. The competitive landscape is pulsating with activities from both established pharmaceutical giants and nimble startups, reflecting a robust but intricate market nature. Companies eager to expand should leverage digital platforms to enhance consumer reach and engage in collaborations for R&D to sustain long-term growth. Addressing educational barriers and destigmatizing the condition through awareness campaigns can further enhance market penetration and consumer engagement.

KEY MARKET STATISTICS
Base Year [2023] USD 3.52 billion
Estimated Year [2024] USD 3.86 billion
Forecast Year [2030] USD 6.77 billion
CAGR (%) 9.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Raising governments awareness of premature ejaculation
    • Increasing prevalence of premature ejaculation
    • Availability of treatment through telehealth
  • Market Restraints
    • Side effects associated with the premature ejaculation treatment
  • Market Opportunities
    • Rising research & development of drugs for treatment
    • Increasing strategic collaborations for development of new diagnostic tools
  • Market Challenges
    • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Premature Ejaculation Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Premature Ejaculation Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Premature Ejaculation Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Premature Ejaculation Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Premature Ejaculation Treatment Market

A detailed market share analysis in the Premature Ejaculation Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Premature Ejaculation Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Premature Ejaculation Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Premature Ejaculation Treatment Market

A strategic analysis of the Premature Ejaculation Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Premature Ejaculation Treatment Market, highlighting leading vendors and their innovative profiles. These include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited, Menarini Group, NeuroHealing Pharmaceuticals Inc., Pfizer Inc., Veru Inc., Wholesome Medtech Private Limited, and zr pharma& GmbH.

Market Segmentation & Coverage

This research report categorizes the Premature Ejaculation Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Dapoxetine, Phosphodiesterase Type 5 (PDE5) Inhibitors, Selective Serotonin Reuptake Inhibitors, Topical Anesthetics, and Zertane.
  • Based on Type, market is studied across Oral Therapies and Topical Therapies. The Oral Therapies is further studied across Nonselective Serotonin Reuptake Inhibitor and Selective Serotonin Reuptake Inhibitor.
  • Based on Dosage Form, market is studied across Pills and Spray.
  • Based on Distribution Channel, market is studied across Hospitals, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Raising governments awareness of premature ejaculation
      • 5.1.1.2. Increasing prevalence of premature ejaculation
      • 5.1.1.3. Availability of treatment through telehealth
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with the premature ejaculation treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising research & development of drugs for treatment
      • 5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Premature Ejaculation Treatment Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Dapoxetine
  • 6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
  • 6.4. Selective Serotonin Reuptake Inhibitors
  • 6.5. Topical Anesthetics
  • 6.6. Zertane

7. Premature Ejaculation Treatment Market, by Type

  • 7.1. Introduction
  • 7.2. Oral Therapies
    • 7.2.1. Nonselective Serotonin Reuptake Inhibitor
    • 7.2.2. Selective Serotonin Reuptake Inhibitor
  • 7.3. Topical Therapies

8. Premature Ejaculation Treatment Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Pills
  • 8.3. Spray

9. Premature Ejaculation Treatment Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Premature Ejaculation Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Premature Ejaculation Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Premature Ejaculation Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ampio Pharmaceuticals, Inc.
  • 2. Aytu BioPharma, Inc.
  • 3. Bayer AG
  • 4. Donga Pharmaceutical Co.,Ltd.
  • 5. Eli Lilly and Company
  • 6. Emcure Pharmaceuticals
  • 7. Futura Medical PLC
  • 8. GlaxoSmithKline PLC
  • 9. Hetero Healthcare Limited
  • 10. Menarini Group
  • 11. NeuroHealing Pharmaceuticals Inc.
  • 12. Pfizer Inc.
  • 13. Veru Inc.
  • 14. Wholesome Medtech Private Limited
  • 15. zr pharma& GmbH

LIST OF FIGURES

  • FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREMATURE EJACULATION TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023